Overview

Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The study will determine if individuals with co-occurring bipolar disorder and alcohol dependence report reduced alcohol consumption, improvement in mood symptoms, and cognitive performance if treated with lamotrigine plus their usual mood stabilizing medications relative to subjects treated with placebo plus usual mood stabilizing medications over a 16 week period.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Treatments:
Anticonvulsants
Ethanol
Lamotrigine